Zevra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
GlobeNewswire
Launch of OLPRUVA^® underwayTopline results from KP1077 phase 2 study demonstrate clinically meaningful benefits for key IH..
Launch of OLPRUVA^® underwayTopline results from KP1077 phase 2 study demonstrate clinically meaningful benefits for key IH..
The ammonia market has shown significant growth, with production increasing from 192 MMT in 2022 to approximately 234 MMT...
HONG KONG, Mar 24, 2024 - (ACN Newswire) - China BlueChemical Ltd. ("China BlueChem" or the "Company," stock code: 3983), China's..